Teng Ling L - OmicsDI

Show results for

Unknown (23)
Metabolomics (2)
Transcriptomics (1)

Organisms

Mus musculus (1)

Repository

MetaboLights (2)
biostudies-arrayexpress (1)

Technology Type

Mass spectrometry assay (2)

Instrument Platform

Liquid Chromatography MS - negative - reverse phase (1)
Liquid Chromatography MS - negative - reverse-phase (1)
Liquid Chromatography MS - positive - reverse phase (1)
Liquid Chromatography MS - positive - reverse-phase (1)

Publication Date

2013 (1)
2026 (1)
2021 (1)

CHEBI ID

CHEBI:116314 (1)
CHEBI:125678 (1)
CHEBI:133086 (1)
CHEBI:133530 (1)
CHEBI:133624 (1)
CHEBI:133683 (1)
CHEBI:134277 (1)
CHEBI:137197 (1)
CHEBI:137230 (1)
CHEBI:137717 (1)
CHEBI:137777 (1)
CHEBI:137852 (1)
CHEBI:137853 (1)
CHEBI:137921 (1)
CHEBI:138422 (1)
CHEBI:138781 (1)
CHEBI:140473 (1)
CHEBI:142245 (1)
CHEBI:142528 (1)
CHEBI:14314 (1)
CHEBI:143245 (1)
CHEBI:144843 (1)
CHEBI:145864 (1)
CHEBI:145961 (1)
CHEBI:15318 (1)
CHEBI:15344 (1)
CHEBI:15521 (1)
CHEBI:15532 (1)
CHEBI:156149 (1)
CHEBI:15625 (1)

Metabolite Name

Alpha-Tocotrienol (2)
Bilirubin (2)
Cis-5-Tetradecenoylcarnitine (2)
Guanine (2)
L-Arginine (2)
Phosphorylcholine (2)
(+)-2,3-Dihydro-3-methyl-1H-pyrrole (1)
(+)-Hyoscyamine (1)
(-)-Morphine (1)
(-)-alpha-Tocopherol (1)
(1R)-4-[18-[(4R)-4-Hydroxy-2,6,6-trimethylcyclohexen-1-yl]-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaenyl]-3,5,5-trimethylcyclohex-3-en-1-ol (1)
(1S,10S,21R)-7-Ethylidene-4,21-di(propan-2-yl)-2-oxa-12,13-dithia-5,8,20,23-tetrazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone (1)
(1S,2S,6R,15S,16R)-5-(Cyclopropylmethyl)-16-(2-hydroxy-3,3-dimethylbutan-2-yl)-15-methoxy-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-11-ol (1)
(1S-Endo)-5-(4-Chloro-3-methylphenyl)-1-((4-methylphenyl)methyl)-N-(1,3,3-trimethylbicyclo(2.2.1)hept-2-yl)-1H-pyrazole-3-carboxamide (1)
(2-Hydroxy-3-phosphonooxypropyl) octadec-9-enoate (1)
(2E,5Z,7E)-Decatrienoylcarnitine (1)
(2R,3R)-2-Aminooctadecane-1,3-diol (1)
(2R,3S,4R,5R,8R,10R,11R,13S,14R)-11-[(2S,3R,4S,6R)-4-(Dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,8,10,12,14-heptamethyl-1-oxa-6-azacyclopentadecan-15-one (1)
(2S)-2-Amino-3-[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]oxypropanoic acid (1)
(2S)-5-(Diaminomethylideneamino)-4-methyl-2-(methylamino)pentanoic acid (1)
(2S)-5-[Carbamimidoyl(methyl)amino]-2-(methylamino)pentanoic acid (1)
(2S)-6-Oxa-1-azabicyclo[3.1.0]hexane-2-carboxylic acid (1)
(2S,3R,4R)-2-Amino-3,4-dihydroxy-2-(hydroxymethyl)-14-oxoicos-6-enoic acid (1)
(2Z)-2-Morpholin-4-yliminoacetonitrile (1)
(3R)-Palonosetron (1)
(9Z)-3-Hydroxydodecenoylcarnitine (1)
(9Z,11E,13E,15Z)-4-Oxo-9,11,13,15-octadecatetraenoic acid (1)
(E)-Raphanusanin (1)
(E,Z)-(1R,2R,3R,5S)-7-(3,5-Dihydroxy-2-((3S)-(3-hydroxy-1-octenyl))cyclopentyl)-5-heptenoic acid (1)
(R)-3-hydroxybutyrylcarnitine (1)

Study type

Transcription profiling by array (1)

Release Date

2021 (5)
2025 (4)
2024 (4)
2013 (3)
2023 (2)
2022 (2)
2020 (1)
2019 (1)
2018 (1)
2016 (1)

Previous page
1 / 3
You're on page 1
page 2
page 3
Next page

Sort by:

Relevance

Page size

Altered metabolome and microbiome features provide clues in understanding irritable bowel syndrome and depression comorbidity

Irritable bowel syndrome (IBS) is one of the functional gastrointestinal disorders characterized by chronic and/or recurrent symptoms of abdominal pain and irregular defecation. Changed gut microbiota has been proposed to mediate IBS; however, contradictory results exist, and IBS-specific microbi...

2021-12-01 | MTBLS2774 | MetaboLights

Metabolomics Study of Flavonoids of Taxilluschinensis on Different Hosts Using UPLC-ESI-MS/MS.

Not available

S-EPMC8704892 | biostudies-literature

Multi-omics Analysis of ACAD11-mediated Lipid Metabolic Reprogramming in the Prognosis of Clear Cell Renal Cell

Clear cell renal cell carcinoma (ccRCC) is pathologically characterized by profound intracellular lipid droplet accumulation. To explore the dysregulated lipid metabolic network and identify crucial drivers, an integrated transcriptomic and untargeted metabolomic analysis was conducted. In this stud...

2026-08-31 | MTBLS15414 | MetaboLights

Treatment to reduce vascular calcification in hemodialysis patients using vitamin K (Trevasc-HDK): A study protocol for a randomized controlled trial.

Not available

S-EPMC7478798 | biostudies-literature

Repurposing flubendazole for glioblastoma ferroptosis by affecting xCT and TFRC proteins.

Not available

S-EPMC11563996 | biostudies-literature

Exploration of the biological mechanisms of CENPA as an oncogene in glioma: Screening based on cancer functional status.

Not available

S-EPMC11610157 | biostudies-literature

Formation of the world's largest REE deposit through protracted fluxing of carbonatite by subduction-derived fluids

Not available